Discover Lipid Biomarkers for Parkinson’s Disease Using MS
Parkinson’s disease (PD) is a neurodegenerative disease that affects 10 million people worldwide. In this webinar, Dr. Roberts will present his research into how lipids may be used as biomarkers for PD.
Changes in the ratios of isomeric lipids, which vary in the position of the double bond or arrangement of the fatty acid chains, have been proven to be useful biomarkers in other diseases including cancer and type 2 diabetes. As lipids are altered in the plasma of PD patients, this is evidence that lipids could be valuable biomarkers for the disease.
In this webinar, Dr. Roberts will highlight how his work aims to identify disease-specific lipid isomers that can be used for the early detection and diagnosis of PD, using ion mobility mass spectrometry.
Attend this webinar to:
- Understand the evidence that suggests lipids could be a valuable biomarker in PD
- Learn about the complexity of lipid metabolism in PD and how this research is used in measuring specific lipids
- Discover how TIMS can be used to identify disease-specific lipid isomers for the early detection of PD
His research group focuses on using protein biochemistry and mass spectrometry to understand Alzheimers, Parkinson’s and amyotrophic lateral sclerosis. He has interest in understanding the role of metals in biology and has developed new proteomic technologies to measure metalloproteins. Further, his group is using mass spectrometry and next generation quantitative assays for the development of new blood borne biomarkers for Alzheimers and Parkinson’s disease.
